BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 22114895)

  • 1. Systemic inflammatory challenges compromise survival after experimental stroke via augmenting brain inflammation, blood- brain barrier damage and brain oedema independently of infarct size.
    Dénes A; Ferenczi S; Kovács KJ
    J Neuroinflammation; 2011 Nov; 8():164. PubMed ID: 22114895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipopolysaccharide preconditioning increased the level of regulatory B cells in the spleen after acute ischaemia/reperfusion in mice.
    Wang Z; Zhou Y; Yu Y; He K; Cheng LM
    Brain Res; 2018 Dec; 1701():46-57. PubMed ID: 29803621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted mutation of Fas ligand gene attenuates brain inflammation in experimental stroke.
    Niu FN; Zhang X; Hu XM; Chen J; Chang LL; Li JW; Liu Z; Cao W; Xu Y
    Brain Behav Immun; 2012 Jan; 26(1):61-71. PubMed ID: 21802508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipopolysaccharide worsens the prognosis of experimental cerebral ischemia via interferon gamma-induced protein 10 recruit in the acute stage.
    Wang P; Zhang J; Guo F; Wang S; Zhang Y; Li D; Xu H; Yang H
    BMC Neurosci; 2019 Dec; 20(1):64. PubMed ID: 31881846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early T1- and T2-weighted MRI signatures of transient and permanent middle cerebral artery occlusion in a murine stroke model studied at 9.4T.
    Barber PA; Hoyte L; Kirk D; Foniok T; Buchan A; Tuor U
    Neurosci Lett; 2005 Nov; 388(1):54-9. PubMed ID: 16055267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fumarate decreases edema volume and improves functional outcome after experimental stroke.
    Clausen BH; Lundberg L; Yli-Karjanmaa M; Martin NA; Svensson M; Alfsen MZ; Flæng SB; Lyngsø K; Boza-Serrano A; Nielsen HH; Hansen PB; Finsen B; Deierborg T; Illes Z; Lambertsen KL
    Exp Neurol; 2017 Sep; 295():144-154. PubMed ID: 28602832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Participation of MCP-induced protein 1 in lipopolysaccharide preconditioning-induced ischemic stroke tolerance by regulating the expression of proinflammatory cytokines.
    Liang J; Wang J; Saad Y; Warble L; Becerra E; Kolattukudy PE
    J Neuroinflammation; 2011 Dec; 8():182. PubMed ID: 22196138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuated Blood-Brain Barrier Dysfunction by XQ-1H Following Ischemic Stroke in Hyperlipidemic Rats.
    Fang W; Sha L; Kodithuwakku ND; Wei J; Zhang R; Han D; Mao L; Li Y
    Mol Neurobiol; 2015 Aug; 52(1):162-75. PubMed ID: 25128027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotection of Resveratrol Against Focal Cerebral Ischemia/Reperfusion Injury in Mice Through a Mechanism Targeting Gut-Brain Axis.
    Dou Z; Rong X; Zhao E; Zhang L; Lv Y
    Cell Mol Neurobiol; 2019 Aug; 39(6):883-898. PubMed ID: 31140018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential role of program death 1-ligand 1 in regulatory T-cell-afforded protection against blood-brain barrier damage after stroke.
    Li P; Mao L; Liu X; Gan Y; Zheng J; Thomson AW; Gao Y; Chen J; Hu X
    Stroke; 2014 Mar; 45(3):857-64. PubMed ID: 24496394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LPS preconditioning redirects TLR signaling following stroke: TRIF-IRF3 plays a seminal role in mediating tolerance to ischemic injury.
    Vartanian KB; Stevens SL; Marsh BJ; Williams-Karnesky R; Lessov NS; Stenzel-Poore MP
    J Neuroinflammation; 2011 Oct; 8():140. PubMed ID: 21999375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Blood-Brain Barrier Disruption in Ischemic Stroke Initiates Multifocally Around Capillaries/Venules.
    Hoffmann A; Dege T; Kunze R; Ernst AS; Lorenz H; Böhler LI; Korff T; Marti HH; Heiland S; Bendszus M; Helluy X; Pham M
    Stroke; 2018 Jun; 49(6):1479-1487. PubMed ID: 29760276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clematichinenoside protects blood brain barrier against ischemic stroke superimposed on systemic inflammatory challenges through up-regulating A20.
    Han D; Fang W; Zhang R; Wei J; Kodithuwakku ND; Sha L; Ma W; Liu L; Li F; Li Y
    Brain Behav Immun; 2016 Jan; 51():56-69. PubMed ID: 26231971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic inflammatory stimulus potentiates the acute phase and CXC chemokine responses to experimental stroke and exacerbates brain damage via interleukin-1- and neutrophil-dependent mechanisms.
    McColl BW; Rothwell NJ; Allan SM
    J Neurosci; 2007 Apr; 27(16):4403-12. PubMed ID: 17442825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal Dexamethasone Reduces Mortality and Brain Damage in a Mouse Experimental Ischemic Stroke Model.
    Espinosa A; Meneses G; Chavarría A; Mancilla R; Pedraza-Chaverri J; Fleury A; Bárcena B; Pérez-Osorio IN; Besedovsky H; Arauz A; Fragoso G; Sciutto E
    Neurotherapeutics; 2020 Oct; 17(4):1907-1918. PubMed ID: 32632775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory and injury responses to ischemic stroke in obese mice.
    Terao S; Yilmaz G; Stokes KY; Ishikawa M; Kawase T; Granger DN
    Stroke; 2008 Mar; 39(3):943-50. PubMed ID: 18239178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endotoxin preconditioning prevents cellular inflammatory response during ischemic neuroprotection in mice.
    Rosenzweig HL; Lessov NS; Henshall DC; Minami M; Simon RP; Stenzel-Poore MP
    Stroke; 2004 Nov; 35(11):2576-81. PubMed ID: 15375302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic Proteasome Inhibition Induces Sustained Post-stroke Neurological Recovery and Neuroprotection via Mechanisms Involving Reversal of Peripheral Immunosuppression and Preservation of Blood-Brain-Barrier Integrity.
    Doeppner TR; Kaltwasser B; Kuckelkorn U; Henkelein P; Bretschneider E; Kilic E; Hermann DM
    Mol Neurobiol; 2016 Nov; 53(9):6332-6341. PubMed ID: 26572637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice.
    McColl BW; Rothwell NJ; Allan SM
    J Neurosci; 2008 Sep; 28(38):9451-62. PubMed ID: 18799677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation.
    Hurn PD; Subramanian S; Parker SM; Afentoulis ME; Kaler LJ; Vandenbark AA; Offner H
    J Cereb Blood Flow Metab; 2007 Nov; 27(11):1798-805. PubMed ID: 17392692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.